Lower Extremity clinical trials

Explore recruiting lower extremity clinical trials.

Recruiting lower extremity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lower Extremity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Use of oral colchicine to determine restenosis in the superficial femoral artery - the COLSTENT study

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

IMPACT OF INTRAVENOUS IRON TREATMENT OF PREOPERATIVE ANEMIA IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERY DISEASE (IRONPAD)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

An open-label, single-arm extension study to evaluate the long-term safety, tolerability, and efficacy of KL1333 (napazimone) in patients with primary mitochondrial disease

Belgium, Germany, Czechia, Spain, Denmark, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1

Netherlands, France, Spain, Denmark, Italy, Ireland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A RandomIzed, Double-Blind, Placebo-CoNtrolled, Two-Part Study to Evaluate the Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients with SoRbitol Dehydrogenase (SORD) DEficiency

Czechia, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: The CONQUER-DVT Randomized Controlled Trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Lower Extremity trials by city

Lower Extremity in Toronto Lower Extremity in Vancouver Lower Extremity in Montreal Lower Extremity in Calgary Lower Extremity in Edmonton Lower Extremity in Ottawa Lower Extremity in Winnipeg Lower Extremity in Quebec City Lower Extremity in Hamilton Lower Extremity in Kitchener Lower Extremity in London Lower Extremity in Halifax Lower Extremity in New York Lower Extremity in Los Angeles Lower Extremity in Chicago Lower Extremity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease